Introduction {#S0001}
============

Cervical cancer is one of the most common malignancies among women worldwide, and the second leading cause of women's cancer-related deaths.[@CIT0001] The main reason of the high mortality is cancer recurrence and metastasis.[@CIT0002] More than 85% of the cervical cancers occur in developing countries, causing serious damage to women's health.[@CIT0003] The mortality of cervical cancer in Chinese women is ranking the second place in the world, with the tendency of younger ages (≤35 years old).[@CIT0004]

MicroRNA (miRNA) is a kind of non-coding, small molecular RNAs, commonly regulating gene expression on post-transcriptional levels.[@CIT0005] Recent research found that miRNA played critical roles in health and disease regulation.[@CIT0006] The abnormal expression of miRNAs results in the occurrence and development of many cancers, including cervical cancer.[@CIT0007],[@CIT0008] Being the important reasons for tumor occurrence and development, cell cycle and cell apoptosis regulation deficiencies could be regulated by miRNAs.[@CIT0009] Researches on miRNA would help discovering the molecular mechanism of cancers to provide evidence for molecular diagnosis, treatment, and prognosis.[@CIT0010]

MiR-940 has been reported as critical regulating element in various cancers. Ma et al revealed that miR-940 inhibited tumorigenesis in nasopharyngeal carcinoma cells.[@CIT0011] Rajendiran et al showed that miR-940 inhibited cell migration and invasion in prostate cancer.[@CIT0012] Yuan et al found that miR-940 was remarkably decreased in hepatocellular carcinoma tissues and cell lines.[@CIT0013] MiR-940 upregulation suppressed cell proliferation and induces apoptosis in ovarian cancer OVCAR3 cells.[@CIT0014] MiR-940 inhibited cell growth and migration in triple-negative breast cancer.[@CIT0015] There was clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.[@CIT0016] In a previous study, Su K et al reported that miR-940 regulated p27 and PTEN post-transcriptionally to regulate human cervical cancer progression.[@CIT0017] Hence, we speculated miR-940 had similar tumor-inhibiting functions in cervical cancer and studied its regulation effect on cell cycle and apoptosis.

At present, the clinical application of gene treatment is not limited by ideal target genes, but lacking proper gene transfection vectors.[@CIT0018],[@CIT0019] Liposome-mediated gene transfection is widely used in labs in vitro experiments.[@CIT0020] But the in vivo poor targeting and low transfection efficiency limit its application in clinical gene treatment.[@CIT0021] Except liposome, virus vectors are of potential safety hazard by conjugating with host chromosomes, though the transfection efficiency is high.[@CIT0022] In addition, the poor targeting and high immunogenicity also limit its further clinical application.[@CIT0023] Recent researchers found that the ultrasound radiation on targeting tissues, after the injection of microbubbles with target genes, could remarkably promote the efficiency of gene transfection and expression.[@CIT0024]

Microbubble ultrasound contrast agent is a new gene transfer vector of safe, stable, and efficient characteristics.[@CIT0025] The microbubble can "break" under the energy of ultrasound radiation, releasing the target gene on it.[@CIT0026] The vibration of microbubble destruction could increase the permeability of local cells and produce a reversible sound-hole, promoting target genes into cell nucleus to increase the efficiency of gene transfection and expression.[@CIT0027] Microbubbles also could protect target genes from degradation by enzymes in blood, decreasing the general side effect.[@CIT0028] Based on the high transfection efficiency and low side effect, the clinical application of microbubble ultrasound contrast agent in gene treatment has attracted a widespread attention.[@CIT0015]

In our study, we studied the effect of microbubble ultrasound contrast agent for gene transfection and demonstrated the molecular mechanism of miR-940 regulating cell proliferation and apoptosis of cervical cancer Hela cells. It would provide new light for cervical cancer treatment.

Materials and methods {#S0002}
=====================

Cell culture {#S0002-S2001}
------------

Human cervical cancer Hela cells were obtained from the cell bank of Chinese Academy of Sciences (Shanghai, China) and cultured in Dulbecco's Modified Eagle Medium (DMEM, Gibco; Waltham, MA, USA) containing 10% fetal bovine serum (FBS, Gemini Bio-products, West-Sacramento, CA, USA) and 1% penicillin/streptomycin (Invitrogen, USA) at 37°C in 5% CO~2~ incubator. The medium was changed once every 2 days. Cell passage was performed when 80% cells confluent. Cells of logarithm phase were used in our research.

Cell transfection {#S0002-S2002}
-----------------

Six fluorinated sulfur (SF6) was applied as microbubble contrast agent in this study, for the high stability, small bubble diameter and long half-life. After entering the human body, most of SF6 enters the alveoli through the lungs and is excreted through the respiratory tract, avoiding safety problem when being used.[@CIT0029] MiR-940 recombined pCMV plasmid and pCMV empty plasmid were purchased from Beyotime company (Nantong, China). Hela cells were divided into five groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group). MiR-940+SF6 group and miR-940+US group were applied to exclude the effects of microbubble and ultrasound to the cells by setting two separate experimental groups for them. For miR-940+SF6+US group, miR-940 recombined plasmid and 10% SF6 microbubble (Bracco Suisse SA, Manno, Switzerland) were added into confluent Hela cells in serum-free media, with the ultrasonic frequency at 2.0 MHz, mechanical index (MI) at 0.28 and irradiation time for 30 s. Optimal ultrasound microbubble was observed by light microscope. For miR-940+US group, miR-940 recombined plasmid was added into Hela confluent cells in serum-free media, and the ultrasound probe, accomplished by coupling agent, was used in the bottom of the culture plate, with the ultrasonic frequency at 2.0 MHz, MI at 0.28 and irradiation time for 30 s. The temperature was monitored and kept between 36 and 37 degree. For miR-940+SF6 group, miR-940 recombined plasmid and 10% SF6 were added into Hela confluent cells in serum-free media and conducted transfection. For miR-940 group, miR-940 recombined pCMV plasmid was transfected into Hela cells using a commonly used liposome -- lipofectamine 3000 (Invitrogen, USA). At the same time, we set up a blank control group transfected with pCMV plasmid, without any other treatment, as Control group. It might be a limitation not setting up experimental groups treated with SF6 only and US only (no miR-940) as control groups. However, miR-940+SF6 group could be the control to detect the effects of US, comparing with miR-940+SF6+US group. miR-940+US group could be the control to detect the effects of SF6, comparing with miR-940+SF6+US group.[@CIT0018] After above transfections, cells were cultured with DMEM containing 10% FBS for 6--8 hrs. Then, mRNA expression of miR-940 was detected by RT-qPCR in above groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group).

MTT assay {#S0002-S2003}
---------

Cell viability was measured by MTT assay. Cells of different groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group) were seeded into 96-well plate at 1×10^4^ cells/well, and detected at different times (12, 24 and 48 hrs). A total of 20 µL MTT was added in each well at 12, 24 and 48 hrs, respectively, and incubated for another 4 hrs. The absorbance was quantified at 490 nm using the Multiskan FC microplate photometer (ThermoFisher, USA), after sediment was solved by DMSO, according to manufacturer's procedures.

Apoptosis analysis {#S0002-S2004}
------------------

The cell apoptosis status was detected by Annexin-Ⅴ/PI (Propidium Iodide) double staining assay after 48 hrs of transfection. Cells of different groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group) were collected and resuspended by 500 μL phosphate buffer solution (PBS, Solarbio, Beijing, China) containing 5 μL Annexin-V fluorescein isothiocyanate and 5 μL PI (Invitrogen, USA). After reaction for 5 mins away from light, cells were detected using BD FACS Calibur flow cytometer (BD, San Diego, CA) and the apoptosis rate was analyzed by BD CellQuestTM Pro Software version 5.1 software.

Cell cycle analysis {#S0002-S2005}
-------------------

Cell cycle progression was evaluated by PI staining after 48 hrs of transfection. Cells of different groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group) were trypsinized, washed twice using PBS and fixed overnight at 4°C in ice-cold 70% ethanol. After being washed twice with PBS again, cells were reacted with PI (50 μg/mL) for 30 mins at room temperature. Cell cycle analysis was immediately performed using a BD FACS Calibur flow cytometer (BD, San Diego, USA). The proportion of cells in G1, S and G2 phases was detected.

Real-time quantitative polymerase chain reaction (RT-qPCR) {#S0002-S2006}
----------------------------------------------------------

Quantification of miR-940 was determined by TaqMan MicroRNA Reverse Transcription Kit (Thermo Fisher, USA). The expression of miR-940 was normalized on the basis of U6. To determine mRNA levels of Puma, Bax, Bcl-2, Cleaved caspase 9, Cyclin D1 and CDK4, total RNA of different groups (Control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group) was firstly reverse transcribed by the Takara PrimeScript RT reagent kit (Takara, Japan). Quantification of mRNA was determined by TaqMan Gene Expression Assay (Thermo Fisher, USA). The pre-heating process was conducted for 25 s at 95°, followed by 40 cycles: denaturation at 95°C for 10 s, annealing/extension at 60°C for 20 s, extension at 72°C for 30 s. Target gene expression was normalized by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primer sequences are listed in [Table 1](#T0001){ref-type="table"}.Table 1Primers used in RT-PCR analysisNameTypeSequencePumaForwardAGATATTGGCGGAAGCCACCReverseCCAGATGCTCTGTCACTGGTBaxForwardTGCTTCAGGGTTTCATCCAReverseGGCCTTGAGCACCAGTTTBcl-2ForwardACGGTGGTGGAGGAGCTCTTReverseCGGTTGACGCTCTCCACACPro-caspase 9ForwardCAGGCAAGCAGCAAAGTTGTReverseGCTGGTCGAAGGTCCTCAAACyclin D1ForwardGCTGGAGGTCTGCGAGGAReverseACAGGAAGCGGTCCAGGTAGTCDK4ForwardCTCTTTGGCAGCTGGTCACATReverseAGGCACCGACACCAATTTCAGAPDHForwardTGACTTCAACAGCGACACCCAReverseCACCCTGTTGCTGTAGCCAAA

Western blot {#S0002-S2007}
------------

Total protein of cells in each group was extracted using ProteoPrep® Total Extraction Sample Kit (Sigma, USA). Concentrations of proteins were tested by Bradford assay (Bio-Rad, USA), and protein samples were separated on 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted to polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, USA). After the blockage with 5% nonfat dry milk for 1 hr at 37°C, membranes were incubated with specific primary antibodies for Puma (Abcam, ab9643, 1:1000), Bax (Abcam, ab53154, 1:1000), Bcl-2 (Abcam ab59348, 1:1000), Cleaved caspase 9 (Abcam, ab2324, 1:1000), Cyclin D1 (Abcam, ab226977, 1:1000), and CDK4 (Abcam, ab137675, 1:2000), PI3K (Abcam, ab133595, 1:2000), AKT (Abcam, ab8805, 1:500), phosphorylated (p)-PI3K (Abcam, ab182651, 1:1000), p-Akt (Abcam, ab38449, 1:1000) and GAPDH (Abcam, ab9485, 1:2000) respectively, overnight at 4°C. Then, they were treated with HRP (horseradish peroxidase)-conjugated secondary antibodies (Abcam, USA) at 37°C for 1 hr and exposed to X-ray ﬁlm. Finally, immunoreactive bands were detected using enhanced chemiluminescence (ECL) detection reagents (Amersham, Arlington Heights, IL, USA). Finally, band densities were quantified by densitometry Bio-Rad ChemiDoc™ XRS+ System with Image Lab™ Software version 4.1 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Data analysis and statistics {#S0002-S2008}
----------------------------

Statistical analyses were performed by SPSS software (version 22.0). Data were presented as the mean±standard deviation from at least three independent experiments.

Turkey's test and one-way ANOVA (analysis of variance) were used in multiple groups for statistical significance. *P*\<0.05 was considered statistically significant different. *P*\<0.01 was considered especially significant different.

Results {#S0003}
=======

The transfection efficiency of miR-940 using microbubble accompanied by ultrasound in cervical cancer cells {#S0003-S2001}
-----------------------------------------------------------------------------------------------------------

First of all, we conducted experiments to evaluate the effect of microbubble ultrasound transfection with miR-940 on cell viabilities of Hela cells, comparing with the transfection method of liposome which was commonly used nowadays. To exclude the effect of microbubble and ultrasound to Hela cells, we set two separate experimental groups for them simultaneously. The microbubble was observed to guarantee acquiring quantities of microbubbles with good shapes ([Figure 1A](#F0001){ref-type="fig"}). The recombined miR-940 plasmids were transfected into Hela cells using different methods, respectively, involving liposome, microbubble, ultrasound and microbubble accompanied by ultrasound. The transfection efficiency was detected by RT-qPCR on miR-940 mRNA levels ([Figure 1B](#F0001){ref-type="fig"}). The miR-940 level in miR-940+SF6+US group was the highest of all, about 4.4-fold of control group transfected with pCMV empty plasmid, without any other treatment, and 2.4-fold of miR-940 group transfected by traditional liposome method. The miR-940 level of miR-940 group was 1.8-fold of control, while the miR-940 levels of miR-940+SF6 group and miR-940+US were similar to each other, about 2.5-fold and 2.6-fold of control, respectively, which were higher than miR-940 group but lower than miR-940+SF6+US group. There was statistically significant difference between each group (*P*\<0.01).Figure 1MiR-940 transfected by microbubble ultrasound inhibited cell viabilities of Hela cells. The plasmids of miR-940 were transfected into Hela cells with different methods, ie, liposome, microbubble, ultrasound and microbubble accompanied by ultrasound. The microbubble image was displayed in (**A**). The transfection efficiency was detected by RT-qPCR on miR-940 levels and displayed in (**B**). Cell viability was detected by MTT assay and displayed in (**C**). Cells of different transfection times (12, 24 and 48 hrs) in different groups were detected. \**P*\<0.05, \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and^\^\^\^^*P*\<0.001 vs miR-940 group.

miR-940 transfected by microbubble ultrasound inhibited cell viabilities of Hela cells {#S0003-S2002}
--------------------------------------------------------------------------------------

Cell viability was detected by MTT assay. Cells of different transfection times (12, 24 and 48 hrs) in different groups were detected. Cell viability decreased as time increased in every group transfected with miR-940. Among all groups, cell viability of miR-940+SF6+US group, about 48.0% of the Control group and 58.5% of the miR-940 group, decreased most at 48 hrs (*P*\<0.01). The viability in miR-940+SF6 group and miR-940+US were similar to each other, about 62.0% and 61.0% of the Control group, respectively, lower than miR-940 group but higher than miR-940+SF6+US group (*P*\<0.05) ([Figure 1C](#F0001){ref-type="fig"}).

miR-940 transfected by microbubble ultrasound promoted cell apoptosis of Hela cells {#S0003-S2003}
-----------------------------------------------------------------------------------

For the proliferation inhibition effect of miR-940 on Hela cells, we performed Annexin-Ⅴ/PI double staining assay to detect the effect of miR-940, transfected by different methods, on Hela cell apoptosis. The apoptosis rate of miR-940+SF6+US group was 18.08%, the highest of all, which was about 3.3-fold of control and 2.1-fold of miR-940 group (*P*\<0.01). The apoptosis rate of miR-940 group (8.57%) was 1.6-fold of control, while that of miR-940+SF6 group (15.82%) and miR-940+US (16.43%) were similar to each other, about 2.9-fold and 3.1-fold of control, respectively, higher than miR-940 group but lower than miR-940+SF6+US group (*P*\<0.01, [Figure 2](#F0002){ref-type="fig"}).Figure 2MiR-940 transfected by microbubble ultrasound promoted cell apoptosis of Hela cells. Annexin-Ⅴ/PI double staining assay was performed to detect the effect of miR-940 transfected by different methods on Hela cell apoptosis. \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and ^\^\^\^^*P*\<0.001 vs miR-940 group.

miR-940 transfected by microbubble ultrasound promoted cell cycle arrest of Hela cells {#S0003-S2004}
--------------------------------------------------------------------------------------

For the inhibition effect of miR-940 on Hela cell proliferation, we performed PI staining assay to measure the function of miR-940, transfected by different methods, on Hela cell cycle arrest. The distribution rates of different phases were measured. As shown in [Figure 3](#F0003){ref-type="fig"}, miR-940 transfected by different methods in Hela cells blocked cell cycle transition from G1 to S phase, at different rates. The percentage of cells in G1-phase was 41.24%, 50.79%, 59.37%, 59.68% and 69.76%, corresponding to control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group, respectively. The percentage of cells in S-phase was 24.19%, 19.59%, 15.13%, 15.29% and 9.26%, corresponding to control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group, respectively. Cell rate of miR-940+SF6+US group in G1-phase was the highest and the rate in its S-phase was the lowest (*P*\<0.01, [Figure 3](#F0003){ref-type="fig"}).Figure 3MiR-940 transfected by microbubble ultrasound promoted cell cycle arrest of Hela cells. PI staining assay was performed to measure the function of miR-940 transfected by different methods on Hela cell cycle arrest. \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and ^\^\^\^^*P*\<0.001 vs miR-940 group.

miR-940 transfected by microbubble ultrasound inhibited cell viabilities of Hela cells via regulating cell cycle- and apoptosis-related factors {#S0003-S2005}
-----------------------------------------------------------------------------------------------------------------------------------------------

To detect the mechanism of miR-940 overexpression inhibiting Hela cell viability, blocking cell cycle and promoting apoptosis, we performed RT-qPCR and Western blot to detect mRNA and protein levels of cell cycle- and apoptosis-related factors such as Puma, Bax, Bcl-2, Caspase 9, Cyclin D1 and CDK4 in the cell groups, including control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group. The results showed that both mRNA and protein levels of Puma and Bax increased significantly in the following order: Control group \< miR-940 group \< miR-940+SF6 group (similar to miR-940+US group) \< miR-940+SF6+US group (*P*\<0.01). On the contrary, both mRNA and protein levels of Bcl-2, Cleaved caspase 9, Cyclin D1 and CDK4 decreased significantly in the following order: Control group \> miR-940 group \> miR-940+SF6 group (similar to miR-940+US group) \> miR-940+SF6+US group (*P*\<0.01). In conclusion, levels of Puma and Bax were the highest, and levels of Bcl-2, Cleaved caspase 9, Cyclin D1 and CDK4 were the lowest in miR-940+SF6+US group ([Figure 4](#F0004){ref-type="fig"} and [Figure 5](#F0005){ref-type="fig"}).Figure 4The mRNA levels of cell cycle- and apoptosis-related factors were regulated by miR-940, which was transfected by microbubble ultrasound. RT-qPCR was performed to detect mRNA levels of cell cycle- and apoptosis-related factors such as Puma, Bax, Bcl-2, Cleaved caspase 9, Cyclin D1 and CDK4 in the cell groups, including control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group. \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and ^\^\^\^^*P*\<0.001 vs miR-940 group.Figure 5The protein levels of cell cycle- and apoptosis-related factors were regulated by miR-940, which was transfected by microbubble ultrasound. Western blot (**A** and **B**) was performed to detect protein levels of cell cycle- and apoptosis-related factors such as Puma, Bax, Bcl-2, Cleaved caspase 9, Cyclin D1 and CDK4 in the cell groups, including control group, miR-940 group, miR-940+SF6 group, miR-940+US group and miR-940+SF6+US group. \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and ^\^\^\^^*P*\<0.001 vs miR-940 group.

miR-940 transfected by microbubble ultrasound inhibited cell viabilities of Hela cells via inhibiting PI3K/Akt pathway {#S0003-S2006}
----------------------------------------------------------------------------------------------------------------------

To determine whether miR-940 regulates PI3K/Akt pathway, we performed Western blot to measure the phosphorylation levels of PI3K and Akt. The results showed that the phosphorylation levels of PI3K and Akt both decreased significantly in the following order: Control group \> miR-940 group (similar to miR-940+SF6 group) \> miR-940+US group \> miR-940+SF6+US group (*P*\<0.05). Phosphorylation levels of PI3K and Akt in miR-940+SF6+US group were both the lowest among all groups. Microbubble alone did not have too much effect on phosphorylation levels regulation, just similar to liposome transfection. But only ultrasound transfection was better than liposome transfection ([Figure 6](#F0006){ref-type="fig"}).Figure 6MiR-940 transfected by microbubble ultrasound inhibited cell viabilities of Hela cells via inhibiting PI3K/Akt pathway. Western blot was performed to measure the phosphorylation levels of PI3K (**A**) and Akt (**B**). \**P*\<0.05, \*\**P*\<0.01 and \*\*\**P*\<0.001 vs control, and ^\^\^\^^*P*\<0.001 vs miR-940 group.

Discussion {#S0004}
==========

Based on the high transfection efficiency and low side effect, the clinical application of microbubble ultrasound contrast agent in gene treatment has attracted a widespread attention.[@CIT0030] In this study, we determined the effects of different transfection methods, including liposome, microbubble, ultrasound and microbubble coupled with ultrasound, on miR-940 transfection into cervical cancer Hela cells, and the variations of cell viability, cell cycle and cell apoptosis. Though the transfection efficiency of virus vectors is also high, the potential safety hazard of conjugating with host chromosomes is also high, so we did not apply virus vector in our study. Through the research, the transfection efficiency of miR-940 transfected with liposome was the lowest and that of miR-940 transfected with microbubble or ultrasonic irradiation was better than liposome. When transfected with ultrasound accompanied by microbubble, the efficiency significantly improved, better than ultrasound or microbubble alone, indicating microbubble and ultrasonic irradiation interacted to promote plasmid transfecting into cells.

The technology of microbubble ultrasound contrast agent mediated gene transfection has the incomparable advantages of high efficiency, low side effect and good targeting effect, which would be a high efficient and good targeting gene transfection system of clinical prospection.[@CIT0031] First, for the ultrasound could be controlled in time and space, it can break microbubble to release target genes at high concentrations in special place, realizing the targeting characteristic.[@CIT0032] Second, for the gas of microbubble are steady, and the short diameter and long half-life period, they can go through lung and respiratory system to be excreted to the outside of the body, therefore possessing low side effect.[@CIT0026] Third, the transfection efficiency is proved better than liposome.[@CIT0033] Microbubble ultrasound contrast agent-mediated gene transfection would be an advantageous transfection method to be widely used in the future. Ultrasound microbubble-mediated miRNA delivery into CD133+ ovarian cancer stem cells and human hepatoma HepG2 cells have been reported, and the effects were found better than the single liposome, microbubble or ultrasound,[@CIT0018],[@CIT0034] which were consistent with our research.

The emphasis of our research is on the novel transfection method of miR-940 transfected with microbubble and ultrasound. In a previous study, Su K et al reported that miR-940 regulated p27 and PTEN post-transcriptionally to regulate human cervical cancer progression,[@CIT0017] which provided support for us using miR-940 as the target gene in our research. In our study, we successfully transfected miR-940 with microbubble and ultrasound, which promoted cervical cancer cell apoptosis, and inhibited cell proliferation significantly, the effect of which was better than the transfection of miR-940 with liposome, microbubble or ultrasound, respectively. Our study found that miR-940 overexpression inhibited Hela cell proliferation. The transfection method of ultrasound combined with microbubble enhanced the inhibition rate, which was higher than the transfection method of liposome, ultrasound or microbubble, respectively. Cell cycle and apoptosis regulation deficiency is an important reason for tumor occurrence and development.[@CIT0035] We found that the miR-940 overexpression transfection by ultrasound combined with microbubble could dramatically promote Hela cell apoptosis and block cell cycle from G1 to S phase, which was better than liposome, ultrasound or microbubble alone.

MiRNAs often regulates cell proliferation by modulating the critical factors in cell cycle and apoptosis, such as cyclin-dependent kinases (CDK), B cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), p53 upregulated modulator of apoptosis (Puma), PI3K/AKT pathway and so on.[@CIT0036] Puma, Bax, Bcl-2 and Caspase 9 are all important cell apoptosis-related genes.[@CIT0037] Bcl-2 is proved to inhibit cell apoptosis rather than promote proliferation by regulating the outer membrane permeability of mitochondria.[@CIT0038] Bax could form heterodimer with Bcl-2 to prevent apoptosis inhibition function of Bcl-2.[@CIT0039] Puma, BH3 domain-containing protein, binds to Bcl-2 to induce cytochrome c release and activate cell apoptosis.[@CIT0040],[@CIT0041] The Puma protein is also reported to promote Bax multimerization to promote apoptosis.[@CIT0042] Puma levels in tumor cells could be promoted by ultraviolet ray, X-radiation, chemotherapy drugs and other treatment methods.[@CIT0043] Caspases are intracellular proteases functioning as apoptosis initiators and effectors. Caspase 9 is critical for cytochrome c dependent apoptosis, which could be activated by Bax and inhibited by Bcl-2.[@CIT0044] Cleaved caspase 9 could be activated by other factors like Apaf-1, forming activated caspase 9 to activate apoptosis.[@CIT0045] Our study found that miR-940 overexpression transfected by ultrasound combined with microbubble increased the expression of Puma and Bax significantly, decreased Cleaved caspase 9 and the expression of apoptosis inhibition factor Bcl-2, indicating more activated caspase 9 to promote apoptosis. The changing degrees of microbubble ultrasound contrast agent group were higher than ultrasound or microbubble alone, and far more than liposome transfection.

Complexes of different Cyclins and CDKs control cell cycle progression orderly. Cyclin D1 and CDK4 are critical factors in cell cycle regulation.[@CIT0046] Cyclin D1 is required for cell cycle progression from G1 to S phase.[@CIT0037],[@CIT0047] The complex of CDK4 and Cyclin D1 is implicated to control cell cycle progression during G1 phase.[@CIT0048] Our study found that miR-940 overexpression decreased the expression of Cyclin D1 and CDK4 to inhibit cell cycle progression. The function of the transfection method of microbubble ultrasound contrast agent was greater, compared with ultrasound, microbubble or liposome methods.

Phosphatidylinositol 3-kinase/Serine/Threonine kinase (PI3K/AKT) signaling pathway is reported to be highly related to tumorigenesis.[@CIT0049] The phosphorylation of Akt activates downstream target genes to regulate cell cycle, proliferation, migration and so on.[@CIT0050] One way is that phosphorylated Akt activates Cyclin D to promote cell cycle G1/S transition. We measured the phosphorylation levels of PI3K and Akt to determine the function of miR-940 overexpression on PI3K/AKT pathway. Our study demonstrated that the phosphorylation levels of Akt and PI3K were decreased by miR-940 overexpression, and the effect of the transfection method of microbubble ultrasound contrast agent was the highest, compared with liposome, microbubble or ultrasound methods. The method of microbubble had little effect on PI3K/AKT phosphorylation. It indicated that miR-940 blocked Hela cell cycle and promoted apoptosis through decreasing phosphorylation and activation of PI3K/AKT pathway. The transfection method of microbubble with ultrasound had the greatest effect of all.

Conclusion {#S0005}
==========

In conclusion, miR-940 transfected with microbubble ultrasound contrast agent is of better transfection efficiency than commonly used liposome and also better than microbubble or ultrasound, respectively. Compared with the transfection of liposome, microbubble or ultrasound, miR-940 transfected with microbubble ultrasound contrast agent showed better effects on inhibiting cell proliferation, blocking cell cycle and promoting apoptosis of cervical cancer cells, which might be associated with the regulation of cell cycle-related factors (such as Cyclin D1 and CDK4) and apoptosis-related factors (such as Puma, Bax, Bcl-2 and Cleaved caspase 9), as well as the inhibition of the phosphorylation and activation of PI3K/AKT pathway. The research provides evidence that, for the high efficiency, low side effects and targeting characteristic, microbubble ultrasound contrast agent would have more wide application in the clinical treatment of cervical cancers. In the future, miR-940 could be a wonderful biomarker and treatment agent for cervical cancer, contributing to the diagnosis, treatment and prognosis of cervical cancer. Certainly, further research needs to be done in more aspects.
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